VANCOUVER, British Columbia, December 18, 2025 - HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical-grade cannabis manufacturer, acknowledges the announcement by the United States administration issuing an executive order directing federal agencies to initiate the reclassification of cannabis to a Schedule III controlled substance under U.S. federal law. The executive order directs the relevant federal authorities to advance the administrative process required to move cannabis from Schedule I to Schedule III under the U.S. Controlled Substances Act. A ...
[ more ]
